Red blood cell and reticulocyte chimerism studies in non-myeloablative allogeneic peripheral blood haematopoietic stem cell transplantation

被引：0
|
作者：
Harritshoj, L [1 ]
Berkowicz, A [1 ]
Petersen, SL [1 ]
Madsen, HO [1 ]
Ryder, LP [1 ]
Vindelov, L [1 ]
Andersen, P [1 ]
Dickmeiss, E [1 ]
机构：
[1] Rigshosp, DK-2100 Copenhagen, Denmark
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S116 / S117
页数：2
相关论文
共 50 条
  • [31] Non-myeloablative haematopoietic stem cell transplants
    Storb, R
    McSweeney, PA
    Sandmaier, BM
    Nash, RA
    Georges, G
    Maloney, D
    Yu, C
    Zaucha, M
    Blume, K
    Shizuru, J
    Niederwieser, D
    HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, : 170 - 174
  • [32] Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation
    Gillis, S
    Eisenberg, ME
    Shapira, MY
    Or, R
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (09): : 671 - 673
  • [33] Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
    Ruiz, Azulamara da Silva
    Ferrari Chauffaille, Maria de Lourdes
    Alves, Solivanda Trindade
    Rodrigues de Oliveira, Jose Salvador
    SAO PAULO MEDICAL JOURNAL, 2009, 127 (05): : 251 - 258
  • [34] A case of successful non-myeloablative allogeneic peripheral blood stem cell transplant for refractory POEMS syndrome
    Kim, CS
    Lee, MH
    Kim, I
    Nahm, CH
    Hyun, DH
    Park, SY
    Choi, SH
    Chung, MH
    Choi, JW
    Kim, SK
    BONE MARROW TRANSPLANTATION, 2003, 31 : S157 - S157
  • [35] Allogenic peripheral blood stem cell infusion may induce chimerism after non-myeloablative conditioning regimen
    De Stefano, F
    Casarino, L
    Corsetti, MT
    Verdiani, S
    Peirano, L
    Carella, AM
    Celesti, R
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 132 - 132
  • [36] Successful non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT) for Waldenström's macroglobulinemia with severe pancytopenia
    T Ueda
    K Hatanaka
    S Kosugi
    B-I Kishino
    T Tamaki
    Bone Marrow Transplantation, 2001, 28 : 609 - 611
  • [37] Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility
    Noborio, K
    Muroi, K
    Izumi, T
    Toshima, M
    Kawano-Yamamoto, C
    Otsuki, T
    Nagai, T
    Komatsu, N
    Ozawa, K
    LEUKEMIA & LYMPHOMA, 2003, 44 (02) : 357 - 359
  • [38] Impact of CD34+ cell dose on the outcome of patients undergoing non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT).
    Diez-Campelo, M
    Perez-Simon, JA
    Martino, R
    Canals, C
    Caballero, D
    Mateos, V
    Sierra, J
    San Miguel, JF
    BLOOD, 2002, 100 (11) : 837A - 837A
  • [39] Quantitative analysis of chimerism after allogeneic stem cell transplantation with non-myeloablative conditioning in paediatric patients
    Di Martino, D.
    Terranova, M. P.
    Di Duca, M.
    Faraci, M.
    Dallorso, S.
    Miano, M.
    Dini, G.
    Morreale, G.
    Lanino, E.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S302 - S303
  • [40] Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
    Yun, Tak
    Lee, Keun-Wook
    Song, Eun-Gi
    Na, Im-Il
    Shin, Hyun-Chun
    Yoon, Sung-Soo
    Park, Seon-Yang
    Kim, Byoung-Kook
    Lee, Jung-Hee
    Choi, Seong-Jun
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    CLINICAL TRANSPLANTATION, 2007, 21 (03) : 337 - 343
12345